These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6953740)

  • 1. Clinical pharmacokinetics of methadone.
    Nilsson MI; Meresaar U; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():66-9. PubMed ID: 6953740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.
    Meresaar U; Nilsson MI; Holmstrand J; Anggård E
    Eur J Clin Pharmacol; 1981; 20(6):473-8. PubMed ID: 7286059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of urinary pH on the disposition of methadone in man.
    Nilsson MI; Widerlöv E; Meresaar U; Anggård E
    Eur J Clin Pharmacol; 1982; 22(4):337-42. PubMed ID: 6286317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.
    Nilsson MI; Anggård E; Holmstrand J; Gunne LM
    Eur J Clin Pharmacol; 1982; 22(4):343-9. PubMed ID: 7106170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state.
    Anggård E; Nilsson MI; Holmstrand J; Gunne LM
    Eur J Clin Pharmacol; 1979 Aug; 16(1):53-7. PubMed ID: 499301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of methadone in healthy subjects and opiate users.
    Wolff K; Rostami-Hodjegan A; Shires S; Hay AW; Feely M; Calvert R; Raistrick D; Tucker GT
    Br J Clin Pharmacol; 1997 Oct; 44(4):325-34. PubMed ID: 9354306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    Garrett ER; Derendorf H; Mattha AG
    J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of methadone in man after a single oral dose.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(6):923-30. PubMed ID: 5081605
    [No Abstract]   [Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of methadone in opioid addicts.
    Wolff K; Hay AW; Raistrick D; Calvert R
    Eur J Clin Pharmacol; 1993; 44(2):189-94. PubMed ID: 8453965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain.
    Inturrisi CE; Colburn WA; Kaiko RF; Houde RW; Foley KM
    Clin Pharmacol Ther; 1987 Apr; 41(4):392-401. PubMed ID: 3829576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective pharmacokinetics of methadone in chronic pain patients.
    Kristensen K; Blemmer T; Angelo HR; Christrup LL; Drenck NE; Rasmussen SN; Sjøgren P
    Ther Drug Monit; 1996 Jun; 18(3):221-7. PubMed ID: 8738759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers.
    Moolenaar F; Fiets G; Visser J; Meijer DK
    Pharm Weekbl Sci; 1984 Dec; 6(6):237-40. PubMed ID: 6549062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment.
    Verebely K; Volavka J; Mulé S; Resnick R
    Clin Pharmacol Ther; 1975 Aug; 18(2):180-90. PubMed ID: 1149368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
    Linardi RL; Stokes AM; Keowen ML; Barker SA; Hosgood GL; Short CR
    Am J Vet Res; 2012 Feb; 73(2):290-5. PubMed ID: 22280392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.
    Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G
    Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.